Relaxo Footwears Ltd
Relaxo Footwears Ltd
Consumer GoodsKey Fundamentals
MicrocapFootwearConsumer GoodsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Relaxo Footwears Ltd insights
46 extracted metrics + investor summaries across FY13–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 43.2%
Weaknesses
3- Stock is trading at 4.41 times its book value
- The company has delivered a poor sales growth of 2.75% over past five years.
- Company has a low return on equity of 8.97% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
Relaxo Footwears Ltd trades at a market cap of ₹10,066 Cr with a PE of 56.7x and ROE of approximately 8-9%, reflecting premium valuation against a backdrop of muted growth. Sales have compounded at just 3% over five years while the stock has declined 19% over the same period, though the company maintains a 43.2% dividend payout ratio.
- Healthy dividend payout ratio of 43.2% indicates shareholder-friendly capital allocation and management confidence in cash flows
- 10-year sales CAGR of 5% and 10-year profit CAGR of 4% demonstrate long-term business resilience through multiple cycles
- 10-year ROE average of 13% suggests the business has historically generated reasonable returns on equity over a full cycle
- TTM profit growth of 5% shows nascent margin recovery after a difficult period of -9% five-year profit CAGR
- Dividend yield of 0.74% provides some income cushion relative to many consumer goods peers trading at similar multiples with lower yields
- Stock decline of 24% over 3 years and 19% over 5 years means valuation has partially corrected from prior peaks, reducing some froth
- Debt-to-equity is not flagged as a concern in known risks, suggesting the balance sheet remains relatively unleveraged for a footwear manufacturer
- PE of 56.7x is extremely elevated for a company delivering only 5% TTM profit growth and negative 3% TTM sales growth
- Price-to-book of 4.61x is high given last-year ROE of just 8%, implying the market pays a steep premium for subpar return generation
- Five-year sales CAGR of only 2.75-3% indicates structural revenue growth challenges in a competitive mass-market footwear segment
- ROE has deteriorated from a 10-year average of 13% to just 8% in the last year, signaling declining capital efficiency
- Five-year profit CAGR of -9% reflects sustained earnings compression despite the company being in a supposedly defensive consumer sector
- Stock has delivered negative returns across 1-year (-10%), 3-year (-24%), and 5-year (-19%) horizons, with only 5% CAGR over 10 years
- TTM sales growth of -3% indicates the top-line is actively contracting, not merely growing slowly
- Three-year ROE of 9% and declining trajectory suggests the premium valuation multiple is increasingly difficult to justify on fundamentals
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- ₹25.67 Cr NSE block trade Jul 17
A block trade of ~5.84 lakh shares executed at ₹439.95/share on NSE, totalling ₹25.67 crore. Likely an institutional rebalancing with no directional signal.
TL;DR: Limited recent news flow for Relaxo Footwears. The only development is a modest ₹25.67 crore block trade on Jul 17, which reflects institutional activity rather than any fundamental change. With no material headwinds or positive catalysts in the news cycle, the near-term outlook hinges on upcoming quarterly results and demand recovery trends in the consumer footwear segment.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 739 | 715 | 713 | 747 | 748 | 679 | 667 | 695 | 654 | 629 | 668 | 751 | 705 |
| Expenses | 631 | 624 | 626 | 627 | 649 | 592 | 584 | 583 | 555 | 547 | 599 | 627 | 597 |
| Operating Profit | 108 | 92 | 87 | 120 | 99 | 88 | 83 | 112 | 99 | 81 | 69 | 124 | 108 |
| OPM % | 15% | 13% | 12% | 16% | 13% | 13% | 12% | 16% | 15% | 13% | 10% | 17% | 15% |
| Other Income | 7 | 11 | 6 | 5 | 5 | 7 | 7 | 8 | 11 | 12 | 11 | 12 | 13 |
| Interest | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Depreciation | 35 | 37 | 38 | 38 | 39 | 40 | 40 | 39 | 40 | 39 | 39 | 39 | 40 |
| PBT | 76 | 60 | 51 | 82 | 60 | 50 | 45 | 75 | 66 | 49 | 36 | 91 | 75 |
| Tax % | 26% | 27% | 24% | 25% | 26% | 26% | 26% | 25% | 26% | 26% | 26% | 25% | 27% |
| Net Profit | 56 | 44 | 39 | 61 | 44 | 37 | 33 | 56 | 49 | 36 | 27 | 68 | 55 |
| EPS in Rs | 2.26 | 1.78 | 1.55 | 2.47 | 1.78 | 1.48 | 1.33 | 2.26 | 1.96 | 1.45 | 1.07 | 2.72 | 2.21 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,441 | 1,668 | 1,631 | 1,941 | 2,292 | 2,410 | 2,359 | 2,653 | 2,783 | 2,914 | 2,790 | 2,702 | 2,753 |
| Expenses | 1,240 | 1,427 | 1,400 | 1,639 | 1,964 | 1,998 | 1,861 | 2,235 | 2,442 | 2,505 | 2,405 | 2,328 | 2,370 |
| Operating Profit | 201 | 241 | 231 | 302 | 328 | 413 | 498 | 418 | 341 | 409 | 385 | 374 | 383 |
| OPM % | 14% | 14% | 14% | 16% | 14% | 17% | 21% | 16% | 12% | 14% | 14% | 14% | 14% |
| Other Income | 0 | 7 | 14 | 4 | 12 | 8 | 22 | 23 | 16 | 29 | 27 | 46 | 48 |
| Interest | 18 | 23 | 15 | 9 | 9 | 19 | 19 | 17 | 22 | 21 | 24 | 22 | 22 |
| Depreciation | 40 | 47 | 51 | 54 | 62 | 109 | 110 | 114 | 125 | 147 | 158 | 157 | 158 |
| PBT | 143 | 178 | 178 | 244 | 268 | 292 | 391 | 311 | 210 | 269 | 230 | 241 | 251 |
| Tax % | 28% | 32% | 33% | 34% | 35% | 22% | 25% | 25% | 26% | 26% | 26% | 26% | — |
| Net Profit | 103 | 120 | 120 | 161 | 175 | 226 | 292 | 233 | 154 | 200 | 170 | 179 | 185 |
| EPS in Rs | 4.29 | 5.01 | 4.99 | 6.69 | 7.07 | 9.11 | 11.74 | 9.35 | 6.21 | 8.05 | 6.84 | 7.2 | 7.45 |
| Div. Payout % | 6% | 6% | 10% | 11% | 13% | 14% | 21% | 27% | 40% | 37% | 44% | 49% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 12 | 12 | 12 | 12 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 362 | 468 | 594 | 749 | 1,093 | 1,248 | 1,548 | 1,735 | 1,830 | 1,976 | 2,073 | 2,181 |
| Borrowings | 239 | 236 | 178 | 153 | 112 | 139 | 144 | 174 | 164 | 205 | 213 | 233 |
| Other Liabilities | 234 | 281 | 286 | 335 | 394 | 430 | 459 | 448 | 476 | 508 | 452 | 510 |
| Total Liabilities | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 | 2,949 |
| Fixed Assets | 472 | 531 | 541 | 525 | 848 | 981 | 938 | 987 | 1,150 | 1,371 | 1,344 | 1,365 |
| CWIP | 2 | 28 | 62 | 138 | 11 | 46 | 118 | 149 | 89 | 33 | 54 | 97 |
| Investments | 0 | 0 | 1 | 1 | 0 | 0 | 338 | 194 | 225 | 108 | 343 | 436 |
| Other Assets | 367 | 438 | 466 | 587 | 752 | 814 | 782 | 1,052 | 1,030 | 1,202 | 1,021 | 1,051 |
| Total Assets | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 | 2,949 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 107 | 159 | 180 | 154 | 123 | 319 | 513 | 56 | 400 | 235 | 406 | 348 |
| Investing | -130 | -130 | -89 | -108 | -56 | -116 | -453 | 15 | -258 | -99 | -262 | -207 |
| Financing | 21 | -31 | -89 | -46 | -68 | -203 | -56 | -70 | -138 | -106 | -162 | -146 |
| Net Cash Flow | -1 | -2 | 1 | 0 | -1 | 1 | 4 | 1 | 3 | 30 | -18 | -5 |
| Free Cash Flow | -23 | 25 | 90 | 46 | 32 | 203 | 391 | -82 | 216 | -11 | 291 | 213 |
| CFO/OP | 72 | 89 | 103 | 78 | 64 | 97 | 121 | 33 | 134 | 74 | 120 | 111 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 24 | 28 | 33 | 35 | 26 | 28 | 34 | 35 | 45 | 41 | 40 |
| Inventory Days | 163 | 147 | 146 | 130 | 130 | 157 | 154 | 202 | 154 | 179 | 177 | 184 |
| Days Payable | 61 | 63 | 63 | 72 | 58 | 65 | 81 | 67 | 69 | 76 | 63 | 87 |
| Cash Conversion Cycle | 123 | 108 | 110 | 90 | 107 | 119 | 101 | 170 | 121 | 148 | 155 | 138 |
| Working Capital Days | 14 | 12 | 19 | 27 | 42 | 57 | 44 | 75 | 59 | 68 | 62 | 89 |
| ROCE % | 30% | 30% | 26% | 30% | 26% | 24% | 26% | 18% | 12% | 14% | 11% | 11% |
Documents
Frequently Asked Questions about Relaxo Footwears Ltd
What does Relaxo Footwears Ltd do?
Where is Relaxo Footwears Ltd (RELAXO) listed?
Which sector does Relaxo Footwears Ltd belong to?
What is the market capitalisation of Relaxo Footwears Ltd?
What is the PE ratio of Relaxo Footwears Ltd?
What is the 52-week high and low of Relaxo Footwears Ltd?
Does Relaxo Footwears Ltd pay dividends?
What is the Return on Equity (ROE) of Relaxo Footwears Ltd?
How can I research Relaxo Footwears Ltd on Tapetide?
Company Information
Incorporated in 1984, Relaxo Footwear Ltd. is the largest footwear manufacturer in India.[1]